Cancer Care Associates Medical Group

Redondo Beach, California 90277

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Early-Stage Breast Carcinoma, Gastroesophageal Junction Adenocarcinoma, HER-2 Positive Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Gastric Adenocarcinoma, Pancreatic Cancer, Urothelial Carcinoma

Studies at this site

• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed
• A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer — Completed
• A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer — Completed
• Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer — Completed
• A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer — Completed
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early